NXP (Nuveen Select Tax Freeome Portfolio) Research & Development: $0.00 Mil (TTM As of Mar. 2026)


NXP Nuveen Select Tax Free Income Portfolio NXP
49 GF Score
Price $14.24
GF Value $16.68
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Nuveen Select Tax Freeome Portfolio Research & Development?

Nuveen Select Tax Freeome Portfolio NXP -0.07% 49 Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus rates NXP with a GF Score™ of 49/100 and a GF Value™ of $16.68 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Nuveen Select Tax Freeome Portfolio's Research & Development for the six months ended in Mar. 2026 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Nuveen Select Tax Freeome Portfolio  (NYSE:NXP) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nuveen Select Tax Freeome Portfolio Research & Development Related Terms

Nuveen Select Tax Freeome Portfolio Research & Development Historical Data

* Premium members only.

The historical data trend for Nuveen Select Tax Freeome Portfolio's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuveen Select Tax Freeome Portfolio Research & Development Chart

Nuveen Select Tax Freeome Portfolio Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nuveen Select Tax Freeome Portfolio Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NXP
49GF Score
Nuveen Select Tax Free Income Portfolio NXP
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nuveen Select Tax Freeome Portfolio Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Nuveen Select Tax Freeome Portfolio (NXP) has a Research & Development of $0.00 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Nuveen Select Tax Freeome Portfolio and its competitors.
Is Nuveen Select Tax Freeome Portfolio's Research & Development too high?
Nuveen Select Tax Freeome Portfolio's current Research & Development is $0.00 Mil. Overall, Nuveen Select Tax Freeome Portfolio has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nuveen Select Tax Freeome Portfolio's Research & Development compare to NIE and RMT?
Nuveen Select Tax Freeome Portfolio's Research & Development of $0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Nuveen Select Tax Freeome Portfolio and its competitors. Nuveen Select Tax Freeome Portfolio's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuveen Select Tax Freeome Portfolio stock overvalued right now?
Based on GuruFocus' analysis, Nuveen Select Tax Freeome Portfolio (NXP) is currently considered Modestly Undervalued. The stock's GF Value™ is $16.68, compared to a current price of $14.24 — trading 14.6% below its estimated fair value. The current Research & Development is $0.00 Mil. Nuveen Select Tax Freeome Portfolio's overall GF Score™ is 49/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Nuveen Select Tax Freeome Portfolio (NXP), the current Research & Development is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nuveen Select Tax Freeome Portfolio (NXP) Overvalued in 2026?

Based on GuruFocus' analysis, Nuveen Select Tax Freeome Portfolio stock appears to be undervalued. The current stock price of $14.24 is trading 14.6% below its estimated GF Value™ of $16.68. GuruFocus considers Nuveen Select Tax Freeome Portfolio to be Modestly Undervalued.

Key valuation signals for NXP:

  • Research & Development: $0.00 Mil
  • GF Value™: $16.68 vs. price of $14.24 (14.6% below fair value)
  • GF Score™: 49/100 with 2 warning signs

No single metric tells the full story. See the NXP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nuveen Select Tax Freeome Portfolio Business Description

Address 333 West Wacker Drive, Chicago, IL, USA, 60606
Nuveen Select Tax Free Income Portfolio is a closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with preservation of capital. The fund has single operating segment.
49GF Score

Get the complete analysis for NXP

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.24
Price
$16.68
GF Value